Lubris Bio Pty Ltd
Clinical trials sponsored by Lubris Bio Pty Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New eye drop offers hope for dry eye in transplant patients Results expected Sep 2026 (estimated)
-
Experimental eye drops for GVHD dry eye show early promise but trial stops short
Disease control Stopped earlyThis study tested a new eye drop (rhPRG4) in 3 adults with moderate to severe dry eye from chronic graft-versus-host disease (GVHD), a complication of bone marrow transplants. The goal was to see if the drops safely improve dryness and eye surface damage. The trial was terminated…
Phase 1/2 • Sponsor: Lubris Bio Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New eye drop shows promise for Sjögren's dry eye relief
Symptom relief Stopped earlyThis early-phase trial tested a new eye drop called rhPRG4 in 8 people with Sjögren's syndrome-related dry eye. Participants received either the active drop or a placebo, then switched after 90 minutes. The study measured eye dryness and safety over a single day. Because the tria…
Phase 1/2 • Sponsor: Lubris Bio Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC